SEC Form 4 · accession 0001104659-18-066729
Neon Therapeutics, Inc. · NTGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert B Bazemore
Director
Period of report
Nov 7, 2018
Accepted (ET)
Nov 7, 2018 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001694187
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $7.56 | Nov 7, 2018 | A | 28,000 | A | — | Nov 6, 2028 | Common Stock | 28,000 | 28,000 | D |
Explanation of responses
- F133% of this option shall vest and become exercisable on November 7, 2019, with the remainder vesting in 24 equal monthly installments thereafter.